Annual contest honors innovations in research and drug
discovery
Washington, DC, June 29, 2005 -- Bio-IT World magazine has named
TGen among the grand prize winners of its third annual Best
Practices Awards Program. The prestigious Bio-IT competition
identifies the best strategies, technologies, and practices that
are transforming the world of research and drug discovery. Entries
are judged by a panel of eight industry experts plus Bio-IT World
editors.
TGen was recognized for combining the leading microarray
technology of Affymetrix and gene discovery software from Silicon
Genetics to develop an industrial-style genotyping pipeline that
has led to the rapid localization and identification of dozens of
disease genes, including a form of Sudden Infant Death
Syndrome.
"Amid extraordinarily tough competition, the accomplishments of
the TGen group in developing a new industrial-strength genotyping
platform really impressed the judges," said Dr. Kevin Davies,
Editor-in-Chief of Bio-IT World. The TGen researchers have already
mapped or identified dozens of disease genes, and we believe that
other groups have a lot to learn from this model. "It's also very
impressive that this world-class facility is being built away from
the traditional US centers of science excellence."
Other winners include Pfizer Global R&D, GlaxoSmithKline,
Harvard Partners Center for Genetics and Genomics, the National
Cancer Institute, and U.K. Trade & Investment.
A panel of expert judges reviewed 33 lengthy submissions from
organizations ranging from large pharmaceutical and biotech
companies to academic institutions.
"When one looks at the list of other institutions receiving this
award and when you consider this national recognition is coming to
an institute less than 3 years old, this is wonderfully
gratifying," said Dr. Jeffrey Trent, TGen's President and
Scientific Director. "Additionally, it provides further validation
for both the translational model being developed at TGen and the
fact that Arizona is becoming nationally competitive in this area
of bioscience."
The Best Practices Awards ceremony was held earlier this week at
the National Press Club in Washington, DC. Dr. Dietrich Stephan,
head of TGen's Neurogenomics Division, accepted the award on behalf
of TGen.
# # #
Media Contacts:
Galen Perry (602) 343-8423
Amy Erickson (602) 343-8522
About TGen
The Translational Genomics Research Institute (TGen) is a
not-for-profit organization whose primary mission is to make and
translate genomic discoveries into advances in human health.
Translational genomics research is a relatively new field employing
innovative advances arising from the human Genome Project to apply
to the development of diagnostics, prognostics and therapies for
cancer, neurological disorders, diabetes and other complex
diseases.